Tradestie Institutional Equity Comparison Engine
RBOT.WS vs CDRE โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
CDRE Overall Edge
CDRE Captures Institutional Edge (4โ0 Pillars ยท 9โ1 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Cadre Holdings, Inc. (CDRE) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, RBOT.WS trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus CDRE at 18.5x Forward P/E and 12.5% operating margin (+30.2% YoY). In options structure, RBOT.WS sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against CDRE sits in SURGE (2nd %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
CDRE
RBOT.WS N/M vs CDRE 18.5x Fwd P/E
Growth & Margin Winner
CDRE
Op Margin N/A vs 12.5% ยท YoY N/A vs +30.2%
Momentum & Technical Winner
CDRE
1Y -67.2% vs -26.4% ยท 52W Pos 0% vs 22%
Options & Structure Winner
CDRE
UNCLASSIFIED (N/A IV) vs SURGE (2nd %ile IV)
RBOT.WS
NYSE
Vicarious Surgical Inc. Warrants, each whole warrant exercisable for 1/30th of a share of Class A Common Stock at an exercise price of $345.00
Orthopedic, Prosthetic & Surgical Appliances & Supplies
$0.01
-24.77% 1D
Market Cap
N/A
1M Return
-67.2%
1Y Return
-67.2%
Forward P/E
N/M
Unified AI Score
50.1 / 100
HOLD
Tech 40.0
Fund 46.0
Flow 50.0
Mom 50.0
CDRE
NYSE
Cadre Holdings, Inc.
Orthopedic, Prosthetic & Surgical Appliances & Supplies
$29.45
-3.63% 1D
Market Cap
$1.3B
1M Return
-0.03%
1Y Return
-26.38%
Forward P/E
18.5x
Unified AI Score
39.6 / 100
SELL
Tech 15.0
Fund 40.0
Flow 55.0
Mom 60.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
RBOT.WS -67.2%
CDRE -26.38%
Spread: +72.55 pp (CDRE Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
RBOT.WS TTM Op. Margin: N/A
CDRE TTM Op. Margin: 12.5%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on RBOT.WS vs CDRE. Trailing 12-month operating profitability (RBOT.WS N/A vs CDRE 12.5%) and valuation multiples (RBOT.WS N/M vs CDRE 18.5x Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | RBOT.WS | CDRE | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | N/A | $1.3B | Larger Scale | CDRE |
| Trailing P/E Ratio Valuation | N/M | 33.6x | Lower Multiple | CDRE |
| Forward P/E Ratio Valuation | N/M | 18.5x | Lower Multiple | CDRE |
| Revenue Growth (YoY) Growth | N/A | +30.2% | Higher Growth | CDRE |
| Operating Margin (TTM) Profitability | N/A | 12.5% | Higher Margin | CDRE |
| Net Profit Margin Profitability | N/A | 5.6% | Higher Margin | CDRE |
| Return on Equity (ROE) Capital Efficiency | N/A | 11.6% | Higher ROE | CDRE |
| 52-Week Range Position Momentum | 0% ($0โ$0) | 22% ($24โ$49) | Stronger Trend | CDRE |
| Beta / 30D Volatility Risk Regime | N/A | 0.87ฮฒ ยท 42% Vol | Lower Realized Risk | CDRE |
| Unified Institutional Score Composite Signal | 50.1 / 100 (HOLD) | 39.6 / 100 (SELL) | Higher Composite | RBOT.WS |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full RBOT.WS vs CDRE Buy Guide
RBOT.WS
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
CDRE
SURGE
9d in phase ยท OBV DISTRIBUTION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
2nd %ile
IV Regime
Compressed (<25th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither RBOT.WS nor CDRE registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.